This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

Pharmaceutical giant Merck (NYSE: MRK) is recognized for its extensive product portfolio of more than 52 drugs covering ...

Pharmaceutical company Merck (NYSE: MRK) was another underperformer on the Dow last month. The stock fell steadily throughout ...

The third-quarter earnings season was at its peak this week for large drugmakers, with several companies — Eli Lilly LLY, ...

Merck & Co reported stronger-than-expected quarterly earnings thanks to rising Keytruda sales. However, Gardasil's weak ...

InProcess-LSP are a young organization, founded in 2014, they have since emerged as providers of groundbreaking process analytical technology for nanoparticle characterization. This article provides a ...

The FDA is proposing the removal of phenylephrine, a popular nasal decongestant, in oral form from over-the-counter use. Here ...

Merck MRK reported third-quarter 2024 adjusted earnings of $1.57 per share, which beat the Zacks Consensus Estimate of $1.50. Earnings declined 26% year over year on a reported basis and 23% excluding ...

Hello Health Rounds Readers! Today we feature a sneak peek at a trio of studies to be presented at the American Heart ...